CAP48 - Autism in Children and Adolescents

NCT ID: NCT06149468

Last Updated: 2025-05-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

500 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-09-15

Study Completion Date

2028-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Evaluation and follow-up of children diagnosed with an autism spectrum disorder in French-speaking Belgium in order to optimize diagnostic protocols, the quality of care required and its accessibility, and to determine the impact of an autism spectrum disorder on schooling, family and society.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The aims of the research project:

* To collect a wide range of data in order to improve knowledge of children with autism spectrum disorder (ASD) in French-speaking Belgium by prospectively including all children and adolescents making a request to the centres of reference. The creation of a common database will make it possible to collect general socio-demographic, geographical and epidemiological data, to characterise the different profiles and to accurately monitor developmental trajectories.
* Evaluate the feasibility and practical implementation of the treatment proposed following a diagnosis of ASD in a child.
* Implement protocols to improve the quality of care for beneficiaries.
* To enable the development of fundamental research protocols. Many questions remain unanswered about the genetic, neuro-cognitive and linguistic characteristics of autism. Only rigorous studies carried out on large, carefully defined samples can advance research.
* Increase public knowledge and understanding of the ASD.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Autism Spectrum Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

ASD group

child/adolescent (under 18 years of age) applying to an autism reference center or being followed up in an autism reference center

inclusion in the register

Intervention Type OTHER

socio-demographic data collection and proposed therapy

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

inclusion in the register

socio-demographic data collection and proposed therapy

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* children/adolescents (under 18 years of age) who apply to an autism reference center or who are followed up in an autism reference center from French-speaking region of Belgium.

Exclusion Criteria

* refusal by the family to allow their child's data to be included in the database.
Maximum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Université Libre de Bruxelles

OTHER

Sponsor Role collaborator

Université de Namur

UNKNOWN

Sponsor Role collaborator

University of Mons

OTHER

Sponsor Role collaborator

Université de Liège

OTHER

Sponsor Role collaborator

Université Catholique de Louvain

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Marine Houssa, PhD

Role: STUDY_CHAIR

Université Catholique de Louvain

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

UCLouvain

Brussels, Brussels Capital, Belgium

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Belgium

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Marie-Cécile Nassogne, Prof

Role: CONTACT

027641061

Marine Houssa, PhD

Role: CONTACT

010474688 ext. 74688

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Marie-Cécile Nassogne, Prof

Role: primary

02 764 1061

Marine Houssa, PhD

Role: backup

010474688 ext. 74688

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CAP48 - TSA

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Early Characteristics of Autism
NCT00090415 COMPLETED PHASE1